Mobilization and purification of CD34+ cells from normal donors-regimens with G-CSF, GM-CSF, or a combination of both
Ho, A.D.; Young, D.; Maruyama, M.; Law, P.; Corringham, R.E.; Mason, J.R.; Oldham, F.; Mills, B.; Terstappen, L.; Lane, T.A.
Bone Marrow Transplantation 17(Suppl 2): S34-S37
1996
ISSN/ISBN: 0268-3369 PMID: 8722332 Document Number: 467591
Document emailed within 1 workday
Related Documents
Körbling, M.; Anderlini, P.; Durett, A.; Maadani, F.; Bojko, P.; Seong, D.; Giralt, S.; Khouri, I.; Andersson, B.; Mehra, R.; vanBesien, K.; Mirza, N.; Przepiorka, D.; Champlin, R. 1996: Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation Bone Marrow Transplantation 18(6): 1073-1079Rosenfeld, C.S.; Bolwell, B.; LeFever, A.; Taylor, R.; List, A.; Fay, J.; Collins, R.; Andrews, F.; Pallansch, P.; Schuster, M.W.; Resta, D.; Levitt, D.; Nemunaitis, J. 1996: Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF Bone Marrow Transplantation 17(2): 179-183
Pérez-Calvo, J.; Fernández-Hidalgo, O.; Subirá, M.L.; Martín-Algarra, S.; Salgado, E.; Brugarolas, A. 2001: Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients Haematologica 86(1): 100-101
Levy, E.M.; Kumar, V.; Bennett, M. 1981: Natural killer activity and suppressor cells in irradiated mice repopulated with a mixture of cells from normal and 89Sr-treated donors Journal of Immunology 127(4): 1428-1432
Gmür, J.; Deluigi, J.; Straub, P.W. 1975: Improvement in the granulocyte harvest from normal donors by means of a combination of "continuous flow" centrifugation and filter leukapheresis Schweizerische Medizinische Wochenschrift 105(47): 1589-1590
Iacone, A.; Quaglietta, A.M.; Dragani, A.; Berardi, A.; Di Bartolomeo, G.; Accorsi, P.; Colamartino, P. 1990: Collection of peripheral blood stem cells in normal donors Haematologica 75(Suppl 1): 33-38
Agrawal, B.; Reddish, M.; Longenecker, B.M. 1996: CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors Journal of Immunology 157(8): 3229-3234
Bensinger, W.I.; Buckner, C.D.; Rowley, S.; Storb, R.; Appelbaum, F.R. 1996: Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells Bone Marrow Transplantation 17(Suppl 2): S19-S21
Cairns, E.; St Germain, J.; Bell, D.A. 1985: The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients Journal of Immunology 135(6): 3839-3844
Li, H.; Wojciechowski, W.; Dell'Agnola, C.; Lopez, N.E.; Espinoza-Delgado, I. 2006: IFN-gamma and T-bet expression in human dendritic cells from normal donors and cancer patients is controlled through mechanisms involving ERK-1/2-dependent and IL-12-independent pathways Journal of Immunology 177(6): 3554-3563
Yecies, L.D.; Johnson, S.M.; Wedner, H.J.; Parker, C.W. 1979: Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. II. Evidence for a precursor role of arachidonic acid and further purification Journal of Immunology 122(5): 2090-2095
Hagenbeek, A.; Martens, A.C. 1981: Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia. II. Velocity sedimentation in combination with density gradient separation Experimental Hematology 9(6): 573-580
Capizzi, R.L. 1981: Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells Cancer Treatment Reports 65(Suppl 4): 115-121
Fregatova, L.M.; Golovacheva, A.A.; Estrina, M.A.; Babenko, E.V.; Zueva, E.E.; Afanas'ev, B.V. 2002: Mobilization of peripheral blood cells for auto- and allogenic transplantations of hemopoietic cells Terapevticheskii Arkhiv 74(7): 27-30
Ueda, M.; Joshi, I.D.; Dan, M.; Uberti, J.P.; Chou, T.H.; Sensenbrenner, L.L.; Lum, L.G. 1993: Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates Transplantation 56(2): 351-356
Kircik, L.H. 2009: Comparative efficacy and safety results of two topical combination acne regimens Journal of Drugs in Dermatology: Jdd 8(7): 624-630
Conti, F.; Sergi, D.; Foggi, P.; Abbate, M.I.; Lopez, M. 2007: New combination chemotherapy regimens in the primary treatment of operable breast cancer La Clinica Terapeutica 158(1): 55-75
Reikvam, A. 1977: Granulocytes and macrophages: mobilization and killing of microorganisms. Normal and pathologic function Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 97(25): 1268-1271
Van der Merwe, A.M.; Falkson, G.; Sandison, A.G.; van Dyk, J.J.; Falkson, H.C. 1973: Advanced lung cancer: a clinical trial of radiotherapy plus two drug combination regimens South African Medical Journal 47(46): 2219-2222
Teicher, B.A.; Alvarez, E.; Liu, P.; Lu, K.; Menon, K.; Dempsey, J.; Schultz, R.M. 1999: MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma Seminars in Oncology 26(2 Suppl 6: 55-62